{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:58:53Z","timestamp":1770969533697,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T00:00:00Z","timestamp":1419292800000},"content-version":"vor","delay-in-days":3309,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1111\/j.1469-0691.2005.01271.x","type":"journal-article","created":{"date-parts":[[2005,9,29]],"date-time":"2005-09-29T13:50:14Z","timestamp":1128001814000},"page":"974-984","source":"Crossref","is-referenced-by-count":98,"title":["Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003)"],"prefix":"10.1016","volume":"11","author":[{"given":"T.R.","family":"Fritsche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Stilwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2005.01271.x_bib1","first-page":"1284","article-title":"The impact of \u03b2\u2010lactamases on the development of novel antimicrobial agents","volume":"3","author":"Bush","year":"2002","journal-title":"Curr Opin Infect Drugs"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jac\/dkg375","article-title":"Properties and potential of ertapenem","volume":"52","author":"Livermore","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/13543784.11.4.529","article-title":"Recent developments in carbapenems","volume":"11","author":"Bonfiglio","year":"2002","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7164\/antibiotics.49.478","article-title":"Synthesis and modification of a novel 1 \u03b2\u2010methyl carbapenem antibiotic, S\u20104661","volume":"49","author":"Iso","year":"1996","journal-title":"J Antibiot"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7164\/antibiotics.49.199","article-title":"A novel 1\u03b2\u2010methylcarbapenem antibiotic, S\u20104661. Synthesis and structure\u2013activity relationships of 2\u2010(5\u2010substituted pyrroldin\u20103\u2010ylthio)\u20101\u03b2\u2010methylcarbapenems","volume":"49","author":"Iso","year":"1996","journal-title":"J Antibiot"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib6","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/jac\/37.5.1034","article-title":"Comparative stability of carbapenem and penem antibiotics to human recombinant dehydropeptidase\u2010I","volume":"37","author":"Mori","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/AAC.42.1.94","article-title":"In vitro and in vivo antibacterial activities of S\u20104661, a new carbapenem","volume":"42","author":"Tsuji","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1128\/AAC.48.4.1384-1396.2004","article-title":"In vitro antimicrobial activity of doripenem, a new carbapenem","volume":"48","author":"Ge","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib9","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.48.8.3136-3140.2004","article-title":"Activities of doripenem (S\u20104661) against drug\u2010resistant clinical pathogens","volume":"48","author":"Jones","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/jac\/dkh298","article-title":"Doripenem (S\u20104661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations","volume":"54","author":"Jones","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000007276","article-title":"Comparative in vitro activity of S\u20104661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens","volume":"46","author":"Watanabe","year":"2000","journal-title":"Chemotherapy"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00003495-199550010-00007","article-title":"Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy","volume":"50","author":"Wiseman","year":"1995","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib13","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/AAC.48.8.3086-3092.2004","article-title":"Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistant selection potential","volume":"48","author":"Mushtaq","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1128\/AAC.48.4.1313-1319.2004","article-title":"Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized \u03b2\u2010lactamases","volume":"48","author":"Mushtaq","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib15","series-title":"Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL","first-page":"10","article-title":"In vivo pharmacodynamic activity of a new carbapenem, doripenem (DOR), against multiple bacteria in a murine thigh infection model [abstract A308]","author":"Andes","year":"2003"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib16","series-title":"Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy","first-page":"2","article-title":"PK\u2010PD target attainment with Monte Carlo simulation (MCS) as decision support of Phase 2\/3 dosing strategies for clinical development of doripenem (DOR) [abstract A\u201011]","author":"Bhavnani","year":"2003"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jac\/46.3.471","article-title":"In vitro and in vivo antibacterial activities of a new injectable carbapenem, S\u20104661, against gynaecological pathogens","volume":"46","author":"Mikamo","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1179\/joc.2002.14.2.155","article-title":"In vitro antibacterial activity of S\u20104661, a new parenteral carbapenem, against urological pathogens isolated from patients with complicated urinary tract infections","volume":"14","author":"Nomura","year":"2002","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib19","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib20","series-title":"Performance standards for antimicrobial susceptibility testing, 14th information supplement","author":"National Committee for Clinical Laboratory Standards","year":"2004"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib21","series-title":"Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario","first-page":"183","article-title":"Clinical studies of S\u20104661, new parenteral carbapenem antibiotic, in complicated urinary tract infections [abstract F218]","author":"Arakawa","year":"1997"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib22","series-title":"Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario","first-page":"183","article-title":"Clinical studies of S\u20104661, new parenteral carbapenem antibiotic, in chronic respiratory tract infections [abstract F219]","author":"Saito","year":"1997"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib23","series-title":"Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL","first-page":"5","article-title":"Doripenem: a phase I study to evaluate safety, tolerability and pharmacokinetics in a western healthy volunteer population [abstract A21]","author":"Thye","year":"2003"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(05)75707-X","article-title":"Worldwide proliferation of carbapenem\u2010resistant Gram\u2010negative bacteria","volume":"354","author":"Kurokawa","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1469-0691.2002.00401.x","article-title":"Emerging carbapanemases in Gram\u2010negative aerobes","volume":"8","author":"Nordmann","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1389201023378427","article-title":"Acquired carbapenem\u2010hydrolyzing \u03b2\u2010lactamases and their genetic support","volume":"3","author":"Poirel","year":"2002","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib27","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1128\/JCM.42.11.5256-5263.2004","article-title":"Metallo\u2010\u03b2\u2010lactamase\u2010producing Gram\u2010negative bacilli: laboratory\u2010based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan","volume":"42","author":"Nishio","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dkg416","article-title":"Dissemination in distinct Brazilian regions of an epidemic carbapenem\u2010resistant Pseudomonas aeruginosa producing SPM metallo\u2010\u03b2\u2010lactamase","volume":"52","author":"Gales","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3201\/eid1003.020799","article-title":"Endemic carbapenem\u2010resistant Pseudomonas aeruginosa with acquired metallo\u2010\u03b2\u2010lactamase determinants in European hospitals","volume":"10","author":"Lagatolla","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jac\/dkh512","article-title":"Italian metallo\u2010\u03b2\u2010lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme","volume":"55","author":"Toleman","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/AAC.39.4.824","article-title":"Plasmid\u2010mediated dissemination of the metallo\u2010\u03b2\u2010lactamase gene blaIMP among clinically isolated isolates of Serratia marcescens","volume":"39","author":"Ito","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/AAC.48.2.648-650.2004","article-title":"Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM\u20104 metallo\u2010\u03b2\u2010lactamase encoded by a conjugative plasmid","volume":"48","author":"Luzzaro","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01271.x_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diagmicrobio.2004.07.003","article-title":"Emerging epidemic of metallo\u2010\u03b2\u2010lactamase\u2010mediated resistances","volume":"51","author":"Jones","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2005.01271.x_bib34","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/344654","article-title":"Bacterial resistance. Origins, epidemiology, and impact","volume":"36","author":"Livermore","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14623922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14623922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T12:47:38Z","timestamp":1553604458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14623922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1198743X14623922"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01271.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}